Review of 'clinical effectiveness' of the TARGIT-A long-term outcomes
Prof. Michael Alvarado
Professor of Surgery, Director of Breast Surgery and Oncology Fellowship at UCSF Health, San Francisco, USA
Director of Breast Surgery talking about the TARGIT-A outcomes from the perspective of an American breast surgeon
In this recorded clinical webinar Prof. Michael Alvarado is presenting his perspective on the recently published 8.6 years results of the TARGIT-A study on breast cancer as Director of Breast Surgery at the UCSF. Overall, Prof. Alvarado is highlighting the aspect of clinical effectiveness, but also gives some insights about treatment efficiency and scientific validation.